Verrica Pharmaceuticals To Host Virtual KOL Event Discussing The Approval Of YCANTHTM (Cantharidin) Topical Solution For The Treatment Of Molluscum On October 11, 2023

Press/Media

Period27 Sep 2023

Media coverage

1

Media coverage

  • TitleVerrica Pharmaceuticals To Host Virtual KOL Event Discussing The Approval Of YCANTHTM (Cantharidin) Topical Solution For The Treatment Of Molluscum On October 11, 2023
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date27/09/23
    PersonsMichael Cameron, Mark Kaufmann
View all 1
View less